Biolimus A9 DEB for the Treatment of In-Stent Restenosis. 1-year outcomes of the REFORM trial.

Back

ESC Professional Premium Access

Biolimus A9 DEB for the Treatment of In-Stent Restenosis. 1-year outcomes of the REFORM trial.

Session: Improving techniques and devices for better outcomes in percutaneous coronary interventions

Topic: Devices

Speaker: Doctor R. Durand (Dublin, IE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rory Durand

Mater Private Hospital, Dublin (Ireland)

1 follower

7 more presentations in this session

A retrospective study on real world, 2-stent left main bifurcation PCI using DK crush technique with IVUS guidance - a single center experience

Speaker: Doctor K. Kaniappan (Kuala Lumpur, MY)

OSDOKINA crush technique for the management of side branch ostial lesion ISTANBOL study

Speaker: Associate Professor I. Donmez (Bolu, TR)

Side branch interventions late after MFM implantation

Speaker: Doctor P. Polomski (Sofia, BG)

Safety and feasibility of drug eluting and perfusion therapy for left main disease: JDEPTH-LM pilot study

Speaker: Doctor T. Warisawa (Tokyo, JP)

Does initial use of large versus small burr size in left main stem bifurcation impact clinical and procedural outcomes?

Speaker: Doctor A. Alatta (Newcastle-Upon-Tyne, GB)

Access the full session

Improving techniques and devices for better outcomes in percutaneous coronary interventions

Speakers: Doctor R. Durand, Doctor K. Kaniappan, Associate Professor I. Donmez, Doctor P. Polomski, Doctor T. Warisawa...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources